Procter & Gamble Co Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $87B+3.3% YoYTTM through 30 Jun 2026
Net Income $16B+0.5% YoYTTM through 30 Jun 2026
Free Cash Flow $15.1BTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Gross Margin | 49.5% |
| EBITDA Margin | 26.3% |
| Operating Margin | 21.5% |
| Net Margin | 18.4% |
Returns
30.3%ROE
12.9%ROA
21.8%ROIC
Balance Sheet Health
Debt / Equity0.68x
Current Ratio0.73x
Net Debt$24.7B
Cash & Equivalents$9.9B
Quality Metrics
Altman Z-Score5.45
Piotroski F-Score7 / 9
FCF Margin17.4%
Rule of 4019.4
Earnings-Beat Rate100.0%
Multi-Year Trend
RevenueFY2026: $87B
Diluted EPS$6.62TTMFY2026: $6.62
Dividend
$2.15Per share, FY20261.45%Yield-8.8%5-yr growth
Capital Allocation
R&D Spend$2.1B
Capex Intensity5.1%
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.